Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Suven Pharmaceuticals Ltd - 543064 - Reg. 34 (1) Annual Report

 This is with reference to our earlier letter dated 21st August, 2020, as per Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the 2nd Annual Report for the financial year 2019-20 which includes Directors' Report, Balance Sheet, Statement of Profit & Loss and Cash Flow Statement. The copy of this Annual Report was earlier submitted under shareholders meeting module. We request you to take the same on your record.
16-09-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Suven Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
15-09-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 This is with reference to our earlier letter dated 21st August, 2020 regarding the 2nd Annual General Meeting (AGM) of the Company held today i.e. 14 September, 2020 and the business mentioned in the Notice dated August 17, 2020 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record.
14-09-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 This is with reference to our earlier letter dated 21st August, 2020 regarding the 2nd Annual General Meeting (AGM) of the Company held today i.e. 14 September, 2020 and the business mentioned in the Notice dated August 17, 2020 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record.
14-09-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 We wish to inform you that senior management team of Suven Pharma is giving corporate presentation in 'Motilal Oswal 16th Annual General Investor Conference' with fund managers and analysts online meeting organized by Motilal Oswal on 3rd - 4th Sept, 2020.
03-09-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated August 21, 2020 regarding Notice of the 2nd AGM, please find enclosed the copies of the newspaper advertisements regarding to Notice of the 2nd Annual General Meeting of the Company and E-Voting Information. The advertisements as appeared on August 22, 2020 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements
24-08-2020

Buy Suven Pharmaceuticals target of Rs 770: ICICI Direct

 ICICI Direct is bullish on Suven Pharmaceuticals recommended buy rating on the stock with a target price of Rs 770 in its research report dated August 19, 2020.
21-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Furnishing Of Notice Of The Second Annual General Meeting (AGM) And Annual Report 2019-20 Under Regulation 34 Of The SEBI (LODR) Regulations, 2015

 With reference to the above subject, pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 2nd AGM of the Members of the Company and the Annual Report for the fiscal 2020 which will be circulated to the shareholders through electronic mode. The 2nd AGM will be held on Monday, September 14, 2020 at 11:30 a.m. IST through Video Conference (VC) / Other Audio Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company's website at: https://www.suvenpharm.com/index.php/investors/financial-info/annual-reports.
21-08-2020

Earnings Call Transcript - Q1FY21 for Suven Pharmaceuticals

 Conference Call with Suven Pharma Management and Analysts on Q1FY21 earnings performance and outlook. Listen to the full earnings transcript.
18-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper advertisement regarding to the 02nd Annual General Meeting of the Company to be held through Video Conferencing (VC)/ Other Audio Visual Means (OVAM)
18-08-2020
Next Page
Close

Let's Open Free Demat Account